Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3
Closed -$158 866
2023
Q3
$158 Hold
3
﹤0.01% 896
2023
Q2
$192 Hold
3
﹤0.01% 901
2023
Q1
$160 Hold
3
﹤0.01% 941
2022
Q4
$161 Hold
3
﹤0.01% 956
2022
Q3
$0 Hold
3
﹤0.01% 931
2022
Q2
$0 Sell
3
-3
-50% -$193 ﹤0.01% 935
2022
Q1
$0 Hold
6
﹤0.01% 950
2021
Q4
$0 Hold
6
﹤0.01% 976
2021
Q3
$1K Sell
6
-3
-33% -$241 ﹤0.01% 1012
2021
Q2
$1K Hold
9
﹤0.01% 995
2021
Q1
$1K Hold
9
﹤0.01% 955
2020
Q4
$1K Sell
9
-10
-53% -$584 ﹤0.01% 931
2020
Q3
$1K Sell
19
-4
-17% -$220 ﹤0.01% 918
2020
Q2
$1K Buy
23
+4
+21% +$177 ﹤0.01% 810
2020
Q1
$1K Buy
+19
New +$1.04K ﹤0.01% 885
2018
Q3
Sell
-22
Closed -$1K 406
2018
Q2
$1K Buy
+22
New +$1.19K ﹤0.01% 864

Other funds holding ENOV

Washington Trust's ENOV Position: Q4 2023 in Review

Washington Trust sold out of Enovis (ENOV) in Q4 2023, closing a stake of 3 shares — an estimated $158 sold.

Washington Trust first reported a position in ENOV in Q2 2018 and held it in 16 quarters. The position peaked at $1K in Q3 2021. 290 funds tracked by Wall St. Rank hold ENOV as of Q4 2023.

  • Washington Trust reported no remaining Enovis position as of Q4 2023 after selling out during the quarter.
  • Washington Trust sold 3 Enovis shares in Q4 2023, an estimated $158.
  • Washington Trust first reported a position in Enovis in Q2 2018 and held it in 16 quarters.
  • Washington Trust's Enovis position peaked at $1K in Q3 2021.
  • 290 funds tracked by Wall St. Rank held Enovis as of Q4 2023.

Based on Washington Trust's 13F filing for Q4 2023, filed 18 Jan 2024.